AAAAAA

   
Results: 1-8 |
Results: 8

Authors: SKINNER R PEARSON ADJ ENGLISH MW PRICE L WYLLIE RA COULTHARD MG CRAFT AW
Citation: R. Skinner et al., CISPLATIN DOSE-RATE AS A RISK FACTOR FOR NEPHROTOXICITY IN CHILDREN, British Journal of Cancer, 77(10), 1998, pp. 1677-1682

Authors: PENG B ENGLISH MW BODDY AV PRICE L WYLLIE R PEARSON ADJ TILBY MJ NEWELL DR
Citation: B. Peng et al., CISPLATIN PHARMACOKINETICS IN CHILDREN WITH CANCER, European journal of cancer, 33(11), 1997, pp. 1823-1828

Authors: ASHRAF MS SKINNER R ENGLISH MW CRAFT AW PEARSON ADJ
Citation: Ms. Ashraf et al., LATE REVERSIBILITY OF CHRONIC IFOSFAMIDE-ASSOCIATED NEPHROTOXICITY INA CHILD, Medical and pediatric oncology, 28(1), 1997, pp. 62-64

Authors: PENG B TILBY MJ ENGLISH MW PRICE L PEARSON ADJ BODDY AV NEWELL DR
Citation: B. Peng et al., PLATINUM-DNA ADDUCT FORMATION IN LEUKOCYTES OF CHILDREN IN RELATION TO PHARMACOKINETICS AFTER CISPLATIN AND CARBOPLATIN THERAPY, British Journal of Cancer, 76(11), 1997, pp. 1466-1473

Authors: ENGLISH MW SKINNER R PEARSON ADJ PRICE L WYLLIE R CRAFT AW
Citation: Mw. English et al., THE INFLUENCE OF IFOSFAMIDE SCHEDULING ON ACUTE NEPHROTOXICITY IN CHILDREN, British Journal of Cancer, 75(9), 1997, pp. 1356-1359

Authors: SKINNER R PEARSON ADJ ENGLISH MW PRICE L WYLLIE RA COULTHARD MG CRAFT AW
Citation: R. Skinner et al., RISK-FACTORS FOR IFOSFAMIDE NEPHROTOXICITY IN CHILDREN, Lancet, 348(9027), 1996, pp. 578-580

Authors: ENGLISH MW LOWIS SP PENG B BODDY A NEWELL DR PRICE L PEARSON ADJ
Citation: Mw. English et al., PHARMACOKINETICALLY GUIDED DOSING OF CARBOPLATIN AND ETOPOSIDE DURINGPERITONEAL-DIALYSIS AND HEMODIALYSIS, British Journal of Cancer, 73(6), 1996, pp. 776-780

Authors: BIN P BODDY AV ENGLISH MW PEARSON ADJ PRICE L TILBY MJ NEWELL DR
Citation: P. Bin et al., THE COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS OF CISPLATIN AND CARBOPLATIN IN PEDIATRIC-PATIENTS - A REVIEW, Anticancer research, 14(6A), 1994, pp. 2279-2283
Risultati: 1-8 |